DERZEMA™

Clobetasol Propionate cream is a high-potency topical corticosteroid widely used in dermatology for the short-term management of severe inflammatory and pruritic skin conditions that do not respond adequately to lower-strength treatments. It works by reducing redness, swelling, itching, and discomfort through its strong anti-inflammatory, antipruritic, and vasoconstrictive properties, helping to calm overactive skin responses and restore visible skin comfort. This medication is commonly prescribed for conditions such as psoriasis, eczema, lichen planus, and other steroid-responsive dermatoses, where rapid control of symptoms is clinically important. Dermapolis has developed DERZEMA™ Clobetasol Propionate cream with a focus on pharmaceutical quality, consistency, and patient usability, ensuring reliable delivery of the active ingredient in a well-tolerated topical formulation. DERZEMA™ is designed to spread easily on the skin, absorb efficiently, and support targeted application to affected areas, which can enhance patient adherence when used under medical supervision. As with all high-potency topical corticosteroids, Clobetasol Propionate cream should be used cautiously and for limited durations, following healthcare professional guidance, to minimize the risk of potential local or systemic side effects. Dermapolis, through its DERZEMA™ brand, is committed to supporting dermatological care by providing treatments that meet rigorous quality standards while addressing the real-world needs of patients managing chronic or severe skin conditions.